AMIRA Meditech is a Bulgarian start-up that is dedicated to addressing the urgent issue of antimicrobial resistance (AMR). The company's slogan, "Bulgarian start-up building a software solution to guide doctors during antibiotic prescription and help fight AMR," reflects its core mission. AMIRA Meditech aims to provide a software solution that guides doctors during antibiotic prescription, offering support to medical specialists to achieve the best possible results for patients. Their software also functions to protect future patients from the emerging problem of AMR. As of now, the founding date, headquarters, and last investment details are not available, indicating that the company is likely in its early stages. However, the potential for AMIRA Meditech to make a significant impact in the healthcare industry and contribute to the global fight against AMR is promising. This presents an interesting opportunity for venture capital firms looking to invest in innovative solutions addressing crucial issues in the medical field.
There is no investment information
No recent news or press coverage available for AMIRA Meditech.